Prescribed List as at 1 September 2021

Information about the publication of Ministerial Decisions

A formal published “Ministerial Decision” is required as a record of the decision of a Minister (or an Assistant Minister where they have delegated authority) as they exercise their responsibilities and powers.

Ministers are elected by the States Assembly and have legal responsibilities and powers as “corporation sole” under the States of Jersey Law 2005 by virtue of their office and in their areas of responsibility, including entering into agreements, and under any legislation conferring on them powers.

An accurate record of “Ministerial Decisions” is vital to effective governance, including:

demonstrating that good governance, and clear lines of accountability and authority, are in place around decisions-making – including the reasons and basis on which a decision is made, and the action required to implement a decision
providing a record of decisions and actions that will be available for examination by States Members, and Panels and Committees of the States Assembly; the public, organisations, and the media; and as a historical record and point of reference for the conduct of public affairs

Ministers are individually accountable to the States Assembly, including for the actions of the departments and agencies which discharge their responsibilities.

The Freedom of Information Law (Jersey) Law 2011 is used as a guide when determining what information is be published. While there is a presumption toward publication to support of transparency and accountability, detailed information may not be published if, for example, it would constitute a breach of data protection, or disclosure would prejudice commercial interest.

A decision made on 9 August 2021

Decision Reference: MD-S-2021-0057
Decision Summary Title :	DS Prescribed list as of 1 September 2021		Date of Decision Summary:
Decision Summary Author:	Policy Principal		Decision Summary: Public or Exempt?	Public
Type of Report: Oral or Written?	Written		Person Giving Oral Report:	NA
Written Report Title :	WR report PBAC 15 July 2021		Date of Written Report:	3 August 2021
Written Report Author:	Prescribing Advisor		Written Report : Public or Exempt?	Public
Subject: Changes to be made to the Prescribed List (Jersey) as of 1 September 2021
Decision(s): Further to Article 15, paragraphs (11) and (12), of the Health Insurance (Jersey) Law 1967, and having consulted with the Pharmaceutical Benefit Advisory Committee, the Minister decided to make amendments to the Prescribed List with effect from 1 July 2021 (unless stated otherwise) as set out in the accompanying report and supporting document.
Reason(s) for Decision: The Pharmaceutical Benefit Advisory Committee met to consider applications for changes to the Prescribed List and made the following recommendations: 1. Items to be added to the Prescribed List from 1 September 2021 1.1 Imiquimod 5% cream (250mg sachets) 1.2 Dorzolamide 20mg/mL eye drops (Eydelto brand) preservative free 1.3 Dorzolamide 20mg/mL, timolol 5mg/mL eye drops (Eylamdo brand) preservative free 1.4 Amlodipine 2.5mg tablets (additional strength) 2. Items to be removed from the Prescribed List (from 1 March 2022) 2.1 Dorzolamide 20mg/mL eye drops 0.2mL unit dose preservative free 2.2 Dorzolamide 20mg/mL, timolol 5mg/mL eye drops 0.2mL unit dose preservative free 3. Items not recommended for inclusion in the Prescribed List 3.1 Cavilon Durable barrier cream 4. Other recommendations 4.1 Liraglutide 6mg/ml solution for injection 3ml pre-filled disposable devices (Saxenda brand) – to pause recommendation to withdrawn reimbursement for this product when supplied as an adjunct to weight management pending review at next meeting The above recommendations reflect current evidence and expert advice and ensure that patients in Jersey have access to an appropriate range of modern, safe and effective treatments from their GPs and community prescribers at a proportionate cost to the Fund.
Resource Implications: The overall financial impact of the above changes is expected to be a cost reduction of around £22,000 pa.
Action required: Health Zone Manager at Customer and Local Services to issue a public notice listing amendments and notify all approved medical practitioners and approved contractors.
Signature:		Position: Minister
Date Signed:		Date of Decision (If different from Date Signed):